2024-03-21 Protein FF meeting note

 

Participants

  • @Pavan Behara

  • @Chapin Cavender

  • @Anika Friedman

  • @Michael Gilson

  • @Alexandra McIsaac

  • @David Mobley

  • @Lily Wang

  • @Brent Westbrook (Unlicensed)

  • @Jeffrey Wagner

  • @Michael Shirts

Goals

  • Benchmarks of protein parameter fits with Sage-2.1 workflow

  • QM parameter fits with AbInitio rather than TorsionProfile targets

Recording

https://drive.google.com/file/d/1qw2I1jMS8nvL4PY1NGsnEzGs9-OOeMUJ/view?usp=sharing

Discussion topics

Item

Presenter

Notes

Item

Presenter

Notes

Sage-2.1 style fit benchmarks

 

@Chapin Cavender

  • Slides

  • Recording

  • Updated fitting workflow to be similar to Sage 2.1, e.g. start from MSM, additional small molecule data, torsions fit from opt geometries, then did experiments on top of that

    • Called 0.0.3 in slides

    • 0.0.3 specific FF captures helicity! at least preliminarily

  • JW: If favorability of alpha is perfect, would value be 0? (slide 8)

    • CC: No, would match value from QM scan. Favorability is relative favorability of alpha vs beta, not FF vs QM

    • DM: Might be easier to parse if you presented error relative to QM

  • JW: is favorability sensitive to boundary drawn between alpha and beta?

    • CC: Yes, although here the minima are usually pretty in the middle of the alpha and beta regions so boundary region isn’t that important

  • PB: What priors are you using?

    • CC: Initial values: 0.0.2 is Sage 2.0.0, 0.0.3 are regularized to MSM or Sage 2.1

    • CC: priors are from Sage 2.1

    • PB: We tightened priors for 2.2

    • CC: Okay, we can try that in the future

  • JW: How to interpret the numbers in slide 9?

    • CC: chi2 – ranks agreement with expt, higher is better

      • average over 15 peptides that we have scalar couplings for, 3-7 residues

      • more details in recording around 15 mins

    • JW: Where column has only 2 bars, were the other ones not run?

      • CC: Yes, only ran the NMR data with the water model it was trained with

    • “ff14SB Only SC” = only fit to side chains (from QM and not scalar couplings); ff14SB backbone is fit to scalar couplings

  • MG: How would delta show up on slide 18 metrics? Would be interesting to look at relative favorability of delta vs alpha, given previous result about delta region being highly sampled by new FF

    • CC: Sure, could compute that. Alpha vs delta will be very sensitive to boundary, since delta is a broad peak surrounding the alpha region

    • MG: Do we have QM results?

    • CC: Not for 15-mer, too big

  • MS: How well does FF14SB only quantum version fold?

    • CC: Haven’t done that yet but interested to look

    • CC: Does better on unstructured peptides, so suspect it would not fold well and might be similar to ours

  • JW: Would expect ideal distribution for AAQAA to be 100% helical?

    • CC: No, expect about 50% helical, but depends a little on what part of the protein

    • JW: Do you know what region the rest of the protein should be?

    • CC: No, just know 50% helix.

  • MS: How would delta show up in data on slide 12?

    • CC: Can’t really distinguish between alpha and delta, either in the experiment or in the computational data. Means it shouldn’t be in a beta sheet or unfolded

  • DM: Are you excited about this? This seems great

    • CC: Yeah, a big relief!

  • MS: Is there a reason we think this fixed it? Or just random?

    • CC: Still benchmarking null model to see if we need specific, seems like null + new workflow does not help helicity. Suggests protein needs to be treated separately

    • MG: Yes but we’ve done null vs specific before, why did this specific one work?

    • CC: Starting from MSM would potentially give better starting point for bonds and angles, doesn’t directly affect torsions but wouldn’t have to account for bad angles/bonds

    • CC: I think it’s just fitting the QM data more precisely, which leads to better helicity. But not immediately clear what fixed it

  • JW: How did 0.0.3 DW do?

    • CC: Does fold to helix but not as good as the non-DW one

  • LW: With helicity plots, would you expect change with more simulation time?

    • CC: For 3-point models, trend will probably stay the same, may expect better sampling of helix terminus (e.g. shape of curve would improve but not height, less noise on edges). For OPC, still needs more time to fold

    • LW: Would that also apply to ratios of secondary structures?

    • CC: Yes

AbInitio target fits

@Chapin Cavender

  • Switch TD for ab initio targets

    • 2D protein TD are very slow

    • Lee-Ping’s FB15 strategy

    • labeled “AI” on slides (great branding)

  • Performs pretty similar to TD version, but makes alpha less favorable

  • JW: What’s up with Null-0.0.3-AI-DW on slide 22?

    • CC: Hard to recover from initial huge objective, initial objective is due to changing type of data

  • LW: Did you try one with only protein TD converted to AI?

    • CC: Yes, didn’t work well, but was starting from 0.0.2 FF, could try again

  • JW: One of themes of the talk is that ff14SB only works with TIP3P, seems like we work well with OPC, which is a better water model

    • MG: Peptide J coupling is a limited benchmark though

    • CC: Sure, but seems to generalize to other benchmarks for larger systems

    • JW: Glad that OPC3 also is good since users won’t be happy about a 4-point water model

    • MS: But 4-point are better, good that we are compatible

  • JW: Glad to see we can get helicity fitting only to QM

Action items

Decisions